Skip to main content
. 2022 Sep 29;12:1017542. doi: 10.3389/fcimb.2022.1017542

Figure 4.

Figure 4

Specificity of the direct ELONA to SARS-CoV-2 S glycoprotein. Non-target proteins, MERS-CoV S glycoprotein, SARS-CoV-2 N protein, HA peptide, and HSA at a concentration of 500 ng/mL coupled with the CoV2-RBD-1C aptamer (1,500 nM) were employed in this study (N = 3). Nuclease-free water was used for the background control, while SARS-CoV-2 S glycoprotein coated with no aptamer served as the negative control. Absorbance was obtained by subtracting the background control from all other wells. All results are presented in ± SEMs. ****p< 0.0001.